Friday, August 29, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

August 2018

Anna by Anna
15 May 2020
in 2018 Digital Magazine
0
Previous Post

July 2018

Next Post

September 2018

Next Post

September 2018

Back to school: Expert guidance from the HSE for a smoother start to the school year

Back to school: Expert guidance from the HSE for a smoother start to the school year

22 August 2025
Pharmacy makes the Top 100

Pharmacy makes the Top 100

18 August 2025
Supporting Enhanced Price Transparency in Pharmacies

Supporting Enhanced Price Transparency in Pharmacies

13 August 2025

RECOMMENDED NEWS

BOOTS ANNOUNCES NEW ONLINE PROCESS FOR EMERGENCY CONTRACEPTION SERVICE

BOOTS ANNOUNCES NEW ONLINE PROCESS FOR EMERGENCY CONTRACEPTION SERVICE

2 years ago
Pharmacists and pharmacy staff experiencing unexplained delays receiving second vaccine dose

Pharmacists and pharmacy staff experiencing unexplained delays receiving second vaccine dose

4 years ago
RCSI researchers discover new way to halt excessive inflammation

RCSI researchers discover new way to halt excessive inflammation

4 years ago
GSK plc has announced positive data from the ZOSTER-049 long-term follow-up phase III trial which followed participants for up to approximately 11 years following initial vaccination with Shingrix (Recombinant Zoster Vaccine or RZV). The final trial data demonstrate that RZV maintains efficacy against shingles for more than a decade in adults over 50. The data presented at the European Congress of Clinical Microbiology and Infectious Diseases (ESCMID) in Barcelona, Spain (27–30 April 2024) is based on the ZOSTER-049 study.1

New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade

1 year ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN